| scholarly article | Q13442814 |
| P2093 | author name string | Katsuhiko Asanuma | |
| Kunimasa Yan | |||
| Yoshimichi Sai | |||
| Yoshihiro Akimoto | |||
| Akihiko Kudo | |||
| Noriko Ito | |||
| Ken-Ichi Miyamoto | |||
| Hitoshi Takenaka | |||
| Yukino Nishibori | |||
| Yugo Ito | |||
| Hisashi Takagi | |||
| P2860 | cites work | Mizoribine Corrects Defective Nephrin Biogenesis by Restoring Intracellular Energy Balance | Q62392677 |
| Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative | Q73378576 | ||
| mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E | Q24301780 | ||
| Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome | Q24314612 | ||
| Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations | Q24540018 | ||
| Amino acid transporter LAT3 is required for podocyte development and function | Q24649770 | ||
| N-linked glycosylation is critical for the plasma membrane localization of nephrin | Q28215172 | ||
| Upstream and downstream of mTOR | Q28277365 | ||
| ER chaperones in mammalian development and human diseases | Q28300625 | ||
| Expression of galectin-1, a new component of slit diaphragm, is altered in minimal change nephrotic syndrome | Q28569367 | ||
| Molecular mechanisms of mTOR-mediated translational control | Q29615529 | ||
| Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression | Q29617473 | ||
| AMP-activated protein kinase: the energy charge hypothesis revisited | Q33183179 | ||
| Quality and quantity control at the endoplasmic reticulum | Q34090425 | ||
| Novel serpinopathy in rat kidney and pancreas induced by overexpression of megsin | Q34405985 | ||
| Orchestrating the unfolded protein response in health and disease | Q35001604 | ||
| TOR signaling: an odyssey from cellular stress to the cell growth machinery | Q36050780 | ||
| Protein quality control in the early secretory pathway | Q36446833 | ||
| Expanding mTOR signaling | Q36902840 | ||
| Minimal change nephropathy and focal segmental glomerulosclerosis | Q36978935 | ||
| The endoplasmic reticulum and the unfolded protein response | Q37006310 | ||
| Endoplasmic reticulum stress responses | Q37014237 | ||
| Endoplasmic reticulum: nutrient sensor in physiology and pathology | Q37435215 | ||
| Endoplasmic reticulum stress and renal disease | Q37512291 | ||
| Endoplasmic reticulum stress in proteinuric kidney disease | Q37610753 | ||
| mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes | Q39914641 | ||
| Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis | Q40002274 | ||
| The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases | Q40305946 | ||
| Amino acid availability regulates p70 S6 kinase and multiple translation factors | Q41913722 | ||
| Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus. | Q42849612 | ||
| Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? | Q43293883 | ||
| Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial | Q46155747 | ||
| Role of the endoplasmic reticulum unfolded protein response in glomerular epithelial cell injury | Q46465778 | ||
| Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis. | Q53940416 | ||
| The podocyte as a direct target of immunosuppressive agents | Q58177753 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1584-1595 | |
| P577 | publication date | 2011-08-29 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | mTORC1 activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome. | |
| P478 | volume | 91 |
| Q85964497 | AKT2 is essential to maintain podocyte viability and function during chronic kidney disease |
| Q36572270 | Angiotensin II induces endoplasmic reticulum stress in podocyte, which would be further augmented by PI3-kinase inhibition |
| Q38017937 | Childhood nephrotic syndrome--current and future therapies |
| Q34571047 | Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis |
| Q38073952 | Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration |
| Q36746091 | Essential Role of X-Box Binding Protein-1 during Endoplasmic Reticulum Stress in Podocytes. |
| Q36956916 | Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways |
| Q91045235 | Hepatic Stearoyl-CoA desaturase-1 deficiency-mediated activation of mTORC1- PGC-1α axis regulates ER stress during high-carbohydrate feeding |
| Q95660603 | Inhibition of mTOR delayed but could not prevent experimental collapsing focal segmental glomerulosclerosis |
| Q54340348 | Mammalian target of rapamycin complex 1 activation in podocytes promotes cellular crescent formation. |
| Q39245624 | Metabolism and homeostasis in the kidney: metabolic regulation through insulin signaling in the kidney |
| Q47574932 | Prohibitin Signaling at the Kidney Filtration Barrier. |
| Q27315815 | Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling |
| Q38012182 | Proteinuria after kidney transplantation |
| Q38206090 | Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease |
| Q58795372 | Puromycin aminonucleoside triggers apoptosis in podocytes by inducing endoplasmic reticulum stress |
| Q34718418 | Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury |
| Q38914374 | Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. |
| Q37995467 | The struggle for energy in podocytes leads to nephrotic syndrome |
| Q36407247 | Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis |
| Q38985872 | USP40 gene knockdown disrupts glomerular permeability in zebrafish |
| Q36100123 | Understanding the mechanisms of proteinuria: therapeutic implications |
| Q51287053 | Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy. |
| Q51126964 | Wolf-Hirschhorn syndrome candidate 1-like 1 epigenetically regulates nephrin gene expression. |
| Q38185017 | mTOR controls kidney epithelia in health and disease |
Search more.